Cardiology Letters, 2022 (vol. 31), issue 2

Comment on 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Lesný P, Gonçalvesová E

Cardiology Letters 2022, 31(2):89-93  

Cardiovascular risk clusters in 2 813 hospitalised seniors

Dúbrava M, Jánošiová J

Cardiology Letters 2022, 31(2):94-99  

Background: Cardiovascular (CV) diseases are distinctive for seniors. Cardiology has been working intensively with risk factors (RF) in recent decades. Their concurrence amplifies the CV risk. Aim: To estimate the prevalence of diabetes (DM), arterial hypertension (AH), dyslipidaemia (DLP), obesity and their clustering in hospitalised patients older than 64 years. Patients and methods: A retrospective observational study with 2 813 unique hospitalised patients (mean age of 78.9 years). Results: AH occurred in 85.4%, DLP in 53.2%, DM in 34.3% and obesity in 27.0%. AH, DLP and obesity were significantly more frequently diagnosed in survivors. Patients...

Combination treatment - a tool to improve the prognosis of patients with pulmonary arterial hypertension

Luknár M, Lesný P, Gonçalvesová E

Cardiology Letters 2022, 31(2):100-106  

Despite significant recent therapeutic advances, pulmonary arterial hypertension remains an incurable disease with an unfavourable prognosis. Treatment decisions are based on risk assessment at diagnosis as well as at regular structured follow-up assessments. Risk stratification according to the European Society of Cardiology is comprehensive. Interpretation of the mosaic of risk status can be subjective and is associated with several issues. This is why risk stratification schemes able to simplify and quantify the risk assessment are needed. This could provide for the objective and optimal choice of treatment strategy. Risk stratification of French...

What is new in patients with HFpEF?

Danková M, Gonçalvesová E

Cardiology Letters 2022, 31(2):107-111  

Heart failure with preserved ejection fraction is common in the population of patients with heart failure syndrome and treatment is difficult. Whereas heart failure with a reduced ejection fraction can be treated with drugs that act to attenuate the overactivation of endogenous neurohormonal systems, therapeutic options for patients with heart failure and a preserved ejection fraction are limited. EMPERORPreserved (The Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction) was carried out to evaluate the effects of SGLT2 inhibition with empagliflozin on major heart failure outcomes. Treatment with empagliflozin...

Indications for speckle tracking echocardiography in routine practice

Dúbrava J

Cardiology Letters 2022, 31(2):112-119  

The potential of speckle tracking echocardiography (STE) is not sufficiently exploited in practice. One of the reasons is the limited awareness of its indications and benefits. The overview publication lists the STE indications according to the official documents of the European Society of Cardiology (ESC), published in 2010-2021 (ESC Guidelines and Consensus and Position papers, published by ESC Councils, ESC Working Groups, European Association of Cardiovascular Imaging, Heart Failure Association). STE has the most significant benefit in diagnosing heart failure with preserved left ventricular ejection fraction, cardiotoxicity in patients undergoing...

Diagnostics of the substrate of myocardial damage after overcoming MINOCA and its clinical significance

Horániová L

Cardiology Letters 2022, 31(2):120-130  

Introduction: Myocardial infarction with nonobstructive coronary arteries (MINOCA) represents an etiologically heterogeneous group of patients, with a differing prognosis compared to patients with myocardial infarction (MI) of atherosclerotic etiology. In comparison to a healthy population, MINOCA carries a 4-fold higher risk of annual mortality from any cause and a high risk of major preventable causes of cardiovascular events (MACE). Currently the diagnosis of MINOCA is not sufficiently established in Slovakia in the fields of interventional cardiology and cardio-radiological imaging. Methods: In our cohort, we analyzed 1131 patients hospitalized...

Sudden cardiac death in athletes and its prevention in Slovakia - a public health issue

Štefan Lukačín, Miloš Kňazovický, Barbora Romžová, Miroslav Kitka

Cardiology Letters 2022, 31(2):131-135  

VYBRANÉ ABSTRAKTY XXXVII. Kongresu Slovenskej hypertenziologickej spoločnosti Slovenskej lekárskej spoločnosti a Konferencie Pracovnej skupiny preventívnej kardiológie Slovenskej kardiologickej spoločnosti 31. marec - 2. apríl 2022, Radisson BLU Carlton Hotel, Bratislava

S. Aziriová et al

Cardiology Letters 2022, 31(2):136-143